173 related articles for article (PubMed ID: 15937504)
41. Pemphigoid-like ocular lesions in patients with graft-versus-host disease following allogeneic bone marrow transplantation.
Karwacka E; Ołdakowska-Jedynak U; Brydak-Godowska J; Paczek L; Kecik D
Transplant Proc; 2006; 38(1):292-4. PubMed ID: 16504728
[TBL] [Abstract][Full Text] [Related]
42. [Infections in bone marrow transplantation].
Villasís-Keever A; Mosqueda JL
Rev Invest Clin; 2005; 57(2):381-6. PubMed ID: 16524081
[No Abstract] [Full Text] [Related]
43. Durable remission of Sézary syndrome after unrelated bone marrow transplantation by reduced-intensity conditioning.
Kahata K; Hashino S; Takahata M; Fujisawa F; Kondo T; Kobayashi S; Fujita Y; Shimizu H; Imamura M; Asaka M
Acta Haematol; 2008; 120(1):14-8. PubMed ID: 18716396
[TBL] [Abstract][Full Text] [Related]
44. Regimen-related mucosal injury of the gut increased the incidence of CMV disease after allogeneic bone marrow transplantation.
Shigematsu A; Yasumoto A; Yamamoto S; Sugita J; Kondo T; Onozawa M; Kahata K; Endo T; Ota S; Sato N; Takahata M; Okada K; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
Biol Blood Marrow Transplant; 2009 Jun; 15(6):679-85. PubMed ID: 19450752
[TBL] [Abstract][Full Text] [Related]
45. Adenovirus infection after pediatric bone marrow transplantation: is treatment always necessary?
Walls T; Hawrami K; Ushiro-Lumb I; Shingadia D; Saha V; Shankar AG
Clin Infect Dis; 2005 May; 40(9):1244-9. PubMed ID: 15825025
[TBL] [Abstract][Full Text] [Related]
46. Liver failure complicating non-alcoholic steatohepatitis following allogeneic bone marrow transplantation for Shwachman-Diamond syndrome.
Ritchie DS; Angus PW; Bhathal PS; Grigg AP
Bone Marrow Transplant; 2002 Jun; 29(11):931-3. PubMed ID: 12080360
[TBL] [Abstract][Full Text] [Related]
47. Urinary excretion of ganciclovir contributes to improvement of adenovirus-associated hemorrhagic cystitis after allogeneic bone marrow transplantation.
Nakazawa Y; Suzuki T; Fukuyama T; Katsuyama Y; Tanaka M; Yanagisawa R; Sakashita K; Shiohara M; Koike K
Pediatr Transplant; 2009 Aug; 13(5):632-5. PubMed ID: 18992066
[TBL] [Abstract][Full Text] [Related]
48. Donor cell-derived myelodysplastic syndrome in a patient 7 years after unrelated allogeneic HLA-mismatched transplantation for Ph+ chronic myeloid leukemia.
Kraut L; Trebeljahr G; Thiele B; Fauser AA
Bone Marrow Transplant; 2005 Oct; 36(8):737. PubMed ID: 16086042
[No Abstract] [Full Text] [Related]
49. Unrelated donor marrow transplantation for B-cell chronic lymphocytic leukemia after using myeloablative conditioning: results from the Center for International Blood and Marrow Transplant research.
Pavletic SZ; Khouri IF; Haagenson M; King RJ; Bierman PJ; Bishop MR; Carston M; Giralt S; Molina A; Copelan EA; Ringdén O; Roy V; Ballen K; Adkins DR; McCarthy P; Weisdorf D; Montserrat E; Anasetti C
J Clin Oncol; 2005 Aug; 23(24):5788-94. PubMed ID: 16043827
[TBL] [Abstract][Full Text] [Related]
50. Hemolytic uremic syndrome after bone marrow transplantation: clinical characteristics and outcome in children.
Hale GA; Bowman LC; Rochester RJ; Benaim E; Heslop HE; Krance RA; Horwitz EM; Cunningham JM; Tong X; Srivastava DK; Handgretinger R; Jones DP
Biol Blood Marrow Transplant; 2005 Nov; 11(11):912-20. PubMed ID: 16275594
[TBL] [Abstract][Full Text] [Related]
51. Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable disease control in myelodysplastic syndrome.
Nakamura R; Rodriguez R; Palmer J; Stein A; Naing A; Tsai N; Chang K; Slovak ML; Bhatia R; Spielberger R; Kogut N; Pullarkat V; Kirschbaum M; Forman SJ; O'Donnell MR
Bone Marrow Transplant; 2007 Nov; 40(9):843-50. PubMed ID: 17724447
[TBL] [Abstract][Full Text] [Related]
52. Matched unrelated bone marrow transplantation with reduced-intensity conditioning for leukocyte adhesion deficiency.
Engel ME; Hickstein DD; Bauer TR; Calder C; Manes B; Frangoul H
Bone Marrow Transplant; 2006 Apr; 37(7):717-8. PubMed ID: 16489359
[No Abstract] [Full Text] [Related]
53. Failure of ribavirin to clear adenovirus infections in T cell-depleted allogeneic bone marrow transplantation.
Hromas R; Clark C; Blanke C; Tricot G; Cornetta K; Hedderman A; Broun ER
Bone Marrow Transplant; 1994 Oct; 14(4):663-4. PubMed ID: 7858548
[No Abstract] [Full Text] [Related]
54. Cytomegalovirus infection after allogeneic transplantation: comparison of cord blood with peripheral blood and marrow graft sources.
Walker CM; van Burik JA; De For TE; Weisdorf DJ
Biol Blood Marrow Transplant; 2007 Sep; 13(9):1106-15. PubMed ID: 17697973
[TBL] [Abstract][Full Text] [Related]
55. Time of onset, viral load, relapse, and duration of active cytomegalovirus infection in bone marrow transplant outcomes.
Habib K; Lamia T; Amel L; Abdelrahmen A; Saloua L; Hana E; Amine S; Bechir Z; Tarek BO; Assia BH
Exp Clin Transplant; 2008 Mar; 6(1):67-73. PubMed ID: 18405248
[TBL] [Abstract][Full Text] [Related]
56. Hemopoietic cell transplantation for the myelodysplastic syndromes.
Scott BL; Deeg HJ
Arch Immunol Ther Exp (Warsz); 2005; 53(4):297-307. PubMed ID: 16088314
[TBL] [Abstract][Full Text] [Related]
57. Transplant strategies for patients with myelodysplastic syndromes.
Deeg HJ
Curr Opin Hematol; 2006 Mar; 13(2):61-6. PubMed ID: 16456370
[TBL] [Abstract][Full Text] [Related]
58. Graft-versus-host disease of the CNS after allogeneic bone marrow transplantation.
Saad AG; Alyea EP; Wen PY; Degirolami U; Kesari S
J Clin Oncol; 2009 Oct; 27(30):e147-9. PubMed ID: 19667266
[No Abstract] [Full Text] [Related]
59. Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and acute myelogenous leukemia.
Valcárcel D; Martino R
Curr Opin Oncol; 2007 Nov; 19(6):660-6. PubMed ID: 17906468
[TBL] [Abstract][Full Text] [Related]
60. Safe and efficacious allogeneic bone marrow transplantation for nonmalignant disorders using partial T cell depletion and no posttransplantation graft-versus-host-disease prophylaxis.
Elhasid R; Arush MB; Zaidman I; Leiba R; Barak AB; Postovsky S; Haddad N; Katz T; Pollack S; Sami I; Gidoni O; Rubin D; Mandel H; Attias D; Reisner Y; Etzioni A; Rowe JM
Biol Blood Marrow Transplant; 2007 Mar; 13(3):329-38. PubMed ID: 17317586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]